Answers are grounded in this paper and cite their sources.
Review reveals limited evidence on pulmonary hypertension in chronic parenchymal lung diseases, highlighting substantial knowledge gaps compared to idiopathic disease forms.
Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as interstitial lung diseases (ILDs), chronic obstructive pulmonary disease (COPD), and many other diffuse parenchymal lung diseases, some of which are very common, the available data is limited. In this paper, we try to browse in the latest available data regarding the occurrence, pathogenesis, and treatment of PH in chronic parenchymal lung diseases.
No takes yet. Share an insight, caveat, or question.
Tsangaris et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: